Orion Corp (ORNBV) Ser B NPV

Sell:€46.90Buy:€46.94€3.69 (7.30%)

Prices delayed by at least 15 minutes
Sell:€46.90
Buy:€46.94
Change:€3.69 (7.30%)
Prices delayed by at least 15 minutes
Sell:€46.90
Buy:€46.94
Change:€3.69 (7.30%)
Prices delayed by at least 15 minutes

Company Information

About this company

Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.

Key people

Liisa Hurme
President, Chief Executive Officer, Member of the Executive Management Board
Rene Lindell
Chief Financial Officer, Member of the Executive Management Board
Julia Irene Macharey
Senior Vice President, People and Culture, Member of the Executive Management Board
Satu Ahomaeki
Senior Vice President, Generics and Consumer Health, Member of the Executive Management Board
Juhani Kankaanpaeae
Senior Vice President, Global Operations, Fermion, Member of the Executive Management Board
Niclas Lindstedt
Senior Vice President, Animal Health, Member of the Executive Management Board
Hao Pan
Senior Vice President, Branded Products, Member of the Executive Management Board
Outi Vaarala
Senior Vice President, Research and Development and Innovative Medicines, Member of the Executive Management Board
Jani Korhonen
Employee Representative on the Executive Management Board
Veli - Matti Mattila
Independent Chairman for the Board
Hilpi Rautelin
Independent Vice Chairman of the Board
Kari Jussi Aho
Independent Director
Maziar Mike Doustdar
Independent Director
Ari Lehtoranta
Independent Director
Click to see more

Key facts

  • EPIC
    ORNBV
  • Location
    Finland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FI0009014377
  • Market cap
    €6.61bn
  • Employees
    3,880
  • Shares in issue
    108.38m
  • Exchange
    Helsinki Stock Exchange
  • Index
    Finland-OMX-Helsinki-All-Share

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.